In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPIGian Matteo Rigolin, Antonio Cuneo, Massimo Negrini et al.|Blood|2017Cited by 99
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristicsGian Matteo Rigolin, Antonio Cuneo, Elena Saccenti et al.|British Journal of Haematology|2018Cited by 45
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlationsGian Matteo Rigolin, Antonio Cuneo, Elena Saccenti et al.|Journal of Hematology & Oncology|2016Cited by 39
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemiaMaurizio Cavallari, Gian Matteo Rigolin, Francesco Cavazzini et al.|Oncotarget|2018Cited by 22
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and <i>TP53</i> disruption as predictors of outcome and chemorefractorinessGian Matteo Rigolin, Antonio Cuneo, Luca Formigaro et al.|Oncotarget|2017Cited by 14